Benzinga's Top #PreMarket Gainers
December 31, 2015 at 08:06 AM EST
Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares rose 21.21 percent to $1.200 after the company reported that the U.S. FDA has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.